British pharmaceutical and biotechnology company, GSK, announced recently that it would cease operations in Nigeria, and instead operate through a third party. For Grey Continent, Cheta Nwanze examines why they’re leaving and what the move says about the state of the Nigerian economy.
![](https://ml3ecjxvie7p.i.optimole.com/cb:tH84.1188a/w:640/h:480/q:mauto/f:best/https://greycontinent.com/wp-content/uploads/2023/08/shutterstock_1123492958-scaled.jpg)